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Testing the Infection Prevalence of Schistosoma mansoni after Mass Drug Administration
by Comparing Sensitivity and Speciﬁcity of Species-Speciﬁc Repeat Fragment Ampliﬁcation
by PCR and Loop-Mediated Isothermal Ampliﬁcation
Miriam Price,1† Austin Cyrs,1† Chummy S. Sikasunge,2 James Mwansa,3 and Nilanjan Lodh1*
1

Department of Clinical Laboratory Science, Marquette University, Milwaukee, Wisconsin; 2Department of Para-clinical Studies,
The University of Zambia, Lusaka, Zambia; 3University Teaching Hospital, The University of Zambia, Lusaka, Zambia

Abstract. Schistosomiasis is a blood parasitic disease caused by trematode parasites of the genus Schistosoma.
Schistosoma mansoni is one of the main contributors of the disease and 90% of the global burden of schistosomiasis is in
Africa. Mass drug administration (MDA) has been implemented to reduce the disease burden in endemic areas. Because
of MDA, the diagnostic sensitivity and speciﬁcity for classical diagnostic tests are reduced. In any disease situation,
diagnosis is vital in determining asymptomatic, concurrent, current, new, and reinfection cases to evaluate the efﬁcacy of
any control program. We have evaluated the positive infection for S. mansoni from ﬁltered urine samples collected from
Zambian school children after MDA using loop-mediated isothermal ampliﬁcation (LAMP) and compared its sensitivity
and speciﬁcity with polymerase chain reaction (PCR). One hundred eleven urine samples collected from school children
aged between 7 and 15 years from Siavonga district in southern Zambia were evaluated by PCR and LAMP for DNA
extracted by two different protocols (ﬁlter-based versus crude extraction). The infection prevalence was 77% with PCR
and almost 94% with mansoni-LAMP. Also, LAMP detected 16% (Qiagen extraction) and 10% (LAMP-Procedure for Ultra
Rapid Extraction) more positive S. mansoni infection than PCR. We have demonstrated the efﬁcacy of LAMP in a
laboratory setup after MDA. The possible inclusion of LAMP as a ﬁeld-based point-of-care test for surveillance can
provide reliable prevalence of schistosomiasis after MDA and help in determining the efﬁcacy of a control program.

INTRODUCTION

diagnostic method, which will use species-speciﬁc DNA detection equally well in high-, medium-, and low-intensity infection settings.
Recently, tests involving nucleic acid ampliﬁcation, such as
polymerase chain reaction (PCR), have shown great sensitivity
and speciﬁcity for S. mansoni for various types of samples.9–12
We have previously detected an S. mansoni–speciﬁc cell-free
repeat DNA fragment captured on ﬁlter paper through urine
ﬁltration via PCR.6,13,14 This approach is devoid of stool
testing and reliance on eggs.15 The inherent technological
limitations of PCR, such as longer time requirement, requirement of gel electrophoresis for visualization, expertise in
molecular biology, and expensive equipment, make it unusable in the ﬁeld or in resource-poor endemic settings.16,17
It has, however, been proposed that loop-mediated isothermal ampliﬁcation (LAMP) can be used as a point-of-care
(POC) assay for ﬁeld diagnostics.18 Loop-mediated isothermal ampliﬁcation uses four primers which amplify six different regions of the target DNA, which occurs at one constant
temperature, and positive reactions will yield changes in color
or turbidity.19 It is more resistant to inhibitors than PCR because it uses Bst polymerase. The sensitivity of LAMP has
been demonstrated to be greater than that of PCR.20 Loopmediated isothermal ampliﬁcation reactions occur quicker
than PCR, amplify DNA fragments independent of the standard thermocycler and electrophoresis, and remove the need
for special reagents. This saves time and money. To use LAMP
as a POC diagnostic test, commercially available Procedure
for Ultra Rapid Extraction (PURE; Figure 1) kit (Eiken Chemical
Co., Ltd, Tokyo, Japan) has been used to rapidly isolate DNA
from clinical samples without potential inhibitors.16,21 This
procedure has been used for tuberculosis,16 pneumonia,21
malaria,9,16,20 and other infectious diseases.
In this study, we have evaluated the performance of LAMP
(as POC diagnosis) for S. mansoni by amplifying the speciesspeciﬁc cell-free repeat DNA fragment (121-bp Sm1-7 repeat

The London Declaration 2020 aims to implement interventions necessary to control or eliminate several neglected
tropical diseases, including schistosomiasis.1 Schistosomiasis in Africa is an ongoing public health problem, which currently infects close to 300 million individuals and more than
700 million people are at risk of getting infected.2 The most
prominent human schistosome, Schistosoma mansoni has
been endemic in 54 countries,3 mostly in Africa. There is a
strong age-speciﬁc relationship with the human population. In
the age group of 6–15 years, the infection prevalence and
intensity peak, resulting into consequences of growth and
cognition delays, attention deﬁcit, poor performance in
school, and a negative effect on the overall growth and quality
of a child’s life.4
Currently, schistosomiasis has been treated routinely
with mass drug administration (MDA5). Because of MDA
control intervention, the detection limit for remaining or new
S. mansoni infection poses a challenge for gold standard
(WHO-recommended) tests and is often missed.6 The gold
standard diagnostic test, Kato-Katz (KK—parasitological) is
low cost and most commonly used, but it lacks sensitivity
for low endemic areas and for the posttreatment situation.7
This diagnostic problem is exacerbated as elimination campaigns progress, and the test becomes less effective and will
miss out detection of asymptomatic carriers, which could
be the likely source of continued transmission. Evaluation
of control programs and disease reemergence needs more
sensitive, speciﬁc, easy-to-use diagnostic tests.8 To address
this issue, there is a need to develop a highly sensitive
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FIGURE 1. Loop-mediated isothermal ampliﬁcation-Procedure for Ultra Rapid Extraction DNA extraction kit. (A) Three components of the
extraction kit. (B) All attached components for DNA extraction represents a closed environment for rapid DNA extraction. This ﬁgure appears in
color at www.ajtmh.org.

fragment, GenBank: M61098.1) from ﬁltered urine samples
collected from Zambian school children after MDA and compared its sensitivity and speciﬁcity against PCR. In addition,
two different DNA extraction kits (Qiagen and PURE kits) were
used for isolation of DNA, which have been compared and
evaluated to see the impact of extracted DNA on the diagnostic performances of LAMP and PCR.
MATERIALS AND METHODS
Study design and sample population. This was a crosssectional study conducted in July 2016 in Siavonga District in
the Southern Province of Zambia. The sample population involved school children aged 7–15 years, who provided consent to participate in the study from their parents either
verbally or in written. Urine and stool samples were collected
1 month after the administration of praziquantel (given at
40 mg/kg). Ethical clearance for conducting this study was
obtained from the Institutional Review Board (IRB) of ERES
Coverage of Zambia (IRB # 2016-Apr-002) and from Marquette University, Milwaukee, WI (IRB # HR-3116).
Sample collection. A total of 111 urine samples were collected from school children (50 males and 60 females). The
same reference number was used for two different sample
types, and two plastic cups were provided in two consecutive
days to the participants for collection of urine on the ﬁrst day
and stool on the second day. About 30–40 mL of urine was
ﬁltered through Whatman #3 ﬁlter paper (Sigma-Aldrich,

St. Louis, MO), which was marked with the same reference
number before ﬁltering the urine. Filter papers were then left to
dry under a ﬂy-proof net and on drying, packed in individual
Ziploc bags with desiccant and shipped to Marquette University, Milwaukee, WI, where they were stored in a refrigerator
at 4°C for further testing. For every participant, age, gender,
locality, and result of the parasitological test were recorded.
Parasitological examination of stool samples for
S. mansoni eggs. The Kato-Katz kit, a WHO-recommended
kit (WHO, Geneva, Switzerland) was used to detect the presence of S. mansoni eggs.22 Two consecutive stool smears
were evaluated for the presence of eggs. Brieﬂy, feces were
pressed through a mesh screen to remove large particles. A
portion of the sieved stool sample was then transferred to the
hole of a template placed on a slide. After ﬁlling the hole on
the template, the template was removed, and the remaining
sample was covered with a piece of cellophane previously
soaked in glycerol–malachite green. The slide was then examined under a microscope for the presence of helminth eggs.
DNA extraction and quantiﬁcation. One hundred eleven
ﬁlter papers were used for DNA extraction by the QIAmp
DNeasy® Blood and Tissue Kit (Qiagen, Hilden, Germany) and
by the LAMP-PURE extraction kit (Eiken Chemical Co., Ltd).
For Qiagen extraction, each ﬁlter paper disc was divided into
four quadrants, and 12 punches (∼1 mm in diameter) were
removed from one quadrant using a regular paper punch. The
scissors and paper punch were washed with 10% bleach and
water between each sample to prevent any contamination.
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The ﬁlter paper punches were mixed with 800 μL of DNA–
RNA-free water (Sigma-Aldrich) and heat-shocked at 95°C
for 10 minutes. The samples were then left on a shaker overnight to ﬁnish the extraction with the Qiagen kit the next day
by following the manufacturer’s protocol. All extracted DNA
samples were quantiﬁed via NanoDrop (Thermo Fisher Scientiﬁc, Waltham, MA) and aliquoted into two tubes of 50 μL
each. The stock and aliquot DNA were stored at −20°C for
ampliﬁcation.
The LAMP-PURE extraction kit composed of three different
units, namely, heating tube, adsorbent tube, and injection cap
(Figure 1). For extraction, 800 μL of the sample was added to
the heating tube and attached with the adsorbent tube, as
the heating was already performed. The powder in the adsorbent tube removed any possible inhibitor. Then, the injection cap was attached. The adsorbent tube was squeezed
over a 1.5-mL Eppendorf tube, and approximately 600 μL
of the extracted DNA was collected per sample. All samples
were quantiﬁed. Loop-mediated isothermal ampliﬁcationProcedure for Ultra Rapid Extraction extraction was a crude
process, which resulted in very high DNA concentrations; all
samples were subjected to dilution using the formula: C1V1 =
C2V2 to concentrations of approximately 5 ng/μL of 100 μL
each for two aliquots. One aliquot for each sample was then
re-quantiﬁed to conﬁrm the concentration. The stock and aliquot DNA were then stored in a −20°C freezer for PCR and
LAMP ampliﬁcation.
Ampliﬁcation of the S. mansoni repeat DNA via PCR and
LAMP. All 111 samples extracted by the Qiagen kit and the
LAMP–PURE kit were ampliﬁed by PCR and LAMP. Polymerase chain reaction ampliﬁcation was carried out in 10 μL
volume with the S. mansoni genomic DNA (BEI Resources,
Manassas, VA) as the positive control, the Schistosoma haematobium genomic DNA (BEI Resources) as the negative
control, template DNA controls were collected from people in
the United States, who have never been exposed to schistosomiasis, and nuclease-free water as the water control
(Sigma-Aldrich). For PCR ampliﬁcation, the reaction volume
consisted of 5 μL of the PCR mastermix (New England Biolabs
Inc., Ipswich, MA), 0.5 μL (10 μM concentration) each of forward and reverse primers, 0.5 μL of 25 mM MgCl2, 2 μL of
DNA (concentration: 4–6 ng/μL), and rest nuclease-free water.

The ampliﬁcation proﬁle included initial denaturation at 95°C
for 10 minutes; then 35 cycles at 95°C for 30 seconds, 57°C for
90 seconds, and 72°C for 45 seconds; and a ﬁnal extension at
72°C for 10 minutes. The same PCR ampliﬁcation protocol
and arrangement was followed for both Qiagen- and LAMP–
PURE-extracted DNA. To conﬁrm ampliﬁcation and correct
amplicon size, PCR products were visualized on a 2% agarose gel stained with SYBR Green (Thermo Scientiﬁc) with a
50-bp reference DNA marker (New England BioLabs Inc.).
Loop-mediated isothermal ampliﬁcation was performed
using the LAMP ready-to-use buffer mix for two separate DNA
templates. The 2× ready-to-use buffer mix was composed of
10× LAMP buffer (Eiken Chemical Co., Ltd), 5 M betaine
(Sigma-Aldrich), and 10 mM dNTPs (Promega, Madison, WI).
The reaction volume for all LAMP ampliﬁcation was 10 μL,
which was composed of 4 μL of ready mix buffer, 0.5 μL each
of LAMP primers (5 pmoles of F3 and B3 and 40 pmoles of
forward inner primer [FIP] and backward inner primer [BIP]),
1 μL of Bst DNA polymerase (New England BioLabs Inc.),
2–3 μL of extracted DNA (4–5 ng/μL in concentration), and 1 μL
of nuclease-free water. The ampliﬁcation was carried out for 2
hours at 63°C with inactivation for 5 minutes at 80°C. Loopmediated isothermal ampliﬁcation products were detected by
adding 1 μL of SYBR Green (1:20 dilution), and a picture was
taken using a cell phone. To conﬁrm the correct ampliﬁed
product, all LAMP products were visualized on 2% agarose
gel stained with SYBR Green and run with a 50-bp reference
ladder. Gel pictures were captured using the Azure c200
system (Azure Biosystems, Dublin, CA). The primers used for
PCR and LAMP were reported in earlier publications.6,13
Statistical analysis. We performed quantitative assessment to evaluate the sensitivity, speciﬁcity, disease prevalence, positive predictive value (PPV), negative predictive
value (NPV), and accuracy of PCR and LAMP ampliﬁcation
for S. mansoni by comparing the two different extraction
methods. The abovementioned statistical analysis was
performed by comparing positive and negative infection
detection by KK and PCR and LAMP for two different DNA
extractions. Disease prevalence was determined based
on the number of positive cases by each diagnostic test
against the total number of samples evaluated. Accuracy
was determined based on the probability of a test of

TABLE 1
Detection of positive and negative infection by KK, PCR, and LAMP for Schistosoma mansoni for both Qiagen- and LAMP-PURE–extracted DNA
A. Comparison of positive and negative infection detection by PCR and LAMP
N: 111 samples

PCR positive

PCR negative

LAMP positive

Qiagen
LAMP-PURE

86 (77.5%)
86 (77.5%)

25
25

104 (93.7%)
97 (87.4%)

N: 111 samples

PCR Qiagen
positive

PCR Qiagen
negative

PCR LAMP-PURE
positive

KK positive
KK negative

9 (8.1%)
77 (69.3%)

25
0

7 (6.3%)
79 (71.8%)

N: 111 samples

LAMP Qiagen
positive

LAMP Qiagen
negative

KK positive
KK negative

9 (8.1%)
95 (85.6%)

0
7

LAMP negative

7
14

B. Comparison of positive and negative infection detection by KK and PCR
PCR LAMP-PURE
negative

2
23

C. Comparison of positive and negative infection detection by KK and LAMP
LAMP LAMP-PURE
positive

8 (7.2%)
89 (80.1%)

KK = Kato-Katz; LAMP-PURE = loop-mediated isothermal ampliﬁcation-Procedure for Ultra Rapid Extraction; PCR = polymerase chain reaction.

LAMP LAMP-PURE
negative

1
13
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TABLE 2
Diagnostic comparison of ampliﬁcation efﬁcacy by PCR and LAMP for Qiagen- and LAMP-PURE–extracted DNA for Schistosoma mansoni
PCR-Qiagen

PCR LAMP-PURE

LAMP-Qiagen

Positive

Negative

LAMP LAMP-PURE

Positive

Negative

Positive
Negative

86
0

18
7

Positive
Negative

74
12

23
2

LAMP-Qiagen
LAMP_LAMP
_PURE

Positive

Positive
Negative

91
13

PCR-Qiagen
Negative

6
1

LAMP_LAMP_PURE

Positive

Negative

Positive
Negative

80
6

17
8

LAMP-PURE = loop-mediated isothermal ampliﬁcation-Procedure for Ultra Rapid Extraction; PCR = polymerase chain reaction.

correctly diagnosing as a positive case. For quantitative
analysis, MedCalc 12.4.0 (MedCalc Software, Ostend, Belgium) was used. Data were processed through JMP 12
(JMP® v12, SAS Institute Inc., Cary, NC) and converted to
numerical values (1 = positive and 0 = negative) for statistical
analysis. JMP was also used to calculate the agreement
statistics by measuring the kappa value and Bowker’s
symmetry. The kappa coefﬁcient determined the agreement
between two tests, where −1 = negative association, 0 =
random, and +1 = full agreement. The Bowker’s symmetry
was a disagreement statistic, which was trying to determine
the symmetry between two tests based on the χ2 approximation of the distribution of the test statistic.23
RESULTS
Detection of positive and negative infection by PCR and
LAMP for two different DNA extraction methods. When
evaluated for PCR ampliﬁcation, both extraction methods
(Qiagen and LAMP-PURE) yielded the same number of positives and negatives. The positive infection rate was 77.5%
(86/111) with PCR for both DNA extractions, whereas it
was almost 94% (104/111) for Qiagen extraction and 87%
(97/111) for LAMP-PURE with LAMP ampliﬁcation (Table 1).
Loop-mediated isothermal ampliﬁcation detected more positive infections than PCR, 18 for Qiagen (16% more) and 11 for
LAMP-PURE (10% more; Table 1). The ﬁndings were consistent with previous study ﬁndings about LAMP being more
sensitive than PCR.24
Detection of positive and negative infection by KK and
comparison against PCR and LAMP. The ampliﬁcation by
PCR and LAMP for Qiagen extraction identiﬁed all of the
samples positively identiﬁed by KK, but yielded signiﬁcantly
more positives by PCR (69.3%) and LAMP (85.6%), which
were eventually KK negative (Table 1). The ampliﬁcation for
LAMP-PURE samples by PCR and LAMP also identiﬁed signiﬁcantly more KK-negative samples, but few KK positives

(two for PCR and one for LAMP) came out as negative
(Table 1).
Comparative analysis of efﬁcacy for ampliﬁcation
methods for different DNA extraction methods. Loopmediated isothermal ampliﬁcation for Qiagen-extracted
samples yielded 18 more positive infections, which were
negative by PCR (total 86) for the same extraction. Similarly,
LAMP-PURE yielded 17 more positive infections than PCR
(total 80), although failed to detect six PCR-positive infections
(Table 2). When PCR for LAMP-PURE–extracted samples
were compared against PCR LAMP-PURE, only 74 were
matched for both, with overlap of negative ampliﬁcation by the
one came out as positive by another ampliﬁcation. Loopmediated isothermal ampliﬁcation for both extracted DNA
improved the outcome with 91 positives for both extractions,
with the 13 remaining undetected for LAMP-PURE extraction
(came out positive for Qiagen). Loop-mediated isothermal
ampliﬁcation-Procedure for Ultra Rapid Extraction–extracted
DNA resulted in some discrepancies for both PCR and LAMP
ampliﬁcation (Table 2).
Disease prevalence estimation, comparison statistics,
and agreement statistics analysis. The diagnostic parameter calculation showed 100% sensitivity (95% CI: 96–100)
and 100% speciﬁcity (95% CI: 59–100) with 94% disease
prevalence for LAMP-Qiagen (Table 3). The predictive value
estimation and accuracy were also 100% for LAMP-Qiagen.
Polymerase chain reaction-Qiagen was the second best test
with 83% sensitivity (95% CI: 74–89) and 100% speciﬁcity
(95% CI: 59–100) and similar disease prevalence (94%). The
PPV was 100% for PCR-Qiagen, but the NPV (28%) and
accuracy (84%) were lower than those of LAMP-Qiagen
(Table 3). Loop-mediated isothermal ampliﬁcation for LAMPPURE showed higher sensitivity (88%; 95% CI: 80–93) and
higher disease prevalence (94%), although it showed lower
speciﬁcity (only 14%; 95% CI: 0.4–58). These ﬁndings were
comparatively lower for PCR for LAMP-PURE with 79% sensitivity (95% CI: 69–86), 31% speciﬁcity (95% CI: 9–61), 88%

TABLE 3
Comparison statistics measured for PCR and LAMP ampliﬁcation for Schistosoma mansoni based on two different extraction techniques
PCR-Qiagen (95% CI)

Sensitivity
Speciﬁcity
Prevalence
PPV
NPV
Accuracy

83% (74–89%)
100% (59–100%)
94%
100%
28%
84%

PCR_LAMP-PURE (95% CI)

79% (69–86%)
31% (9–61%)
88%
90%
16%
73%

LAMP-Qiagen (95% CI)

LAMP_LAMP_PURE (95% CI)

100% (96–100%)
100% (59–100%)
94%
100%
100%
100%

88% (80–93%)
14% (0.4–58%)
94%
94%
7%
83%

LAMP-PURE = loop-mediated isothermal ampliﬁcation-Procedure for Ultra Rapid Extraction; NPV = negative predictive value; PCR = polymerase chain reaction; PPV = positive predictive value.
The infection prevalence identiﬁed by each extraction technique is highlighted in bold to emphasize the difference.
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TABLE 4
Agreement statistics estimation (kappa coefﬁcient and Bowker symmetry test) comparing species-speciﬁc DNA ampliﬁcation by PCR and LAMP for
both Qiagen- and LAMP-PURE–extracted DNA for Schistosoma mansoni
Kappa coefﬁcient

Bowker’s symmetry test*

Comparison of diagnostic tests

Degree of agreement

95% CI

Symmetry of disagreement

P-value†

PCR-Qiagen vs. LAMP-Qiagen
PCR-Qiagen vs. PCR_LAMP-PURE
PCR-Qiagen vs. LAMP_LAMP-PURE
LAMP-Qiagen vs. LAMP_LAMP-PURE

0.38
−0.08
0.30
0.01

0.17–0.58
−0.25–0.09
0.08–0.51
−0.17–0.19

18
0
5.26
2.58

0.0001‡
1.0000
0.0218‡
0.1083

LAMP-PURE = loop-mediated isothermal ampliﬁcation-Procedure for Ultra Rapid Extraction; PCR = polymerase chain reaction.
* Bowker’s symmetry test = this test checks for symmetry in two-way tables and the test decision is based on a χ2 approximation of the distribution of the test statistic.
† α level was set at 0.05.
‡ Signiﬁcant. P-values are highlighted in bold.

disease prevalence, and lowest accuracy value (73%) of them
all (Table 3). The PPV values for all four combinations were
close and ranged from 90% to 100%. However, NPVs were
variable, as it was 100% for LAMP-Qiagen and signiﬁcantly
lower for LAMP_LAMP-PURE (7%) and PCR_LAMP-PURE
(16%; Table 3).
Test positives for PCR-Qiagen were highly likely to be the
same with LAMP-Qiagen, although LAMP was more sensitive
for Qiagen-extracted samples (Bowker = 18, P = 0.001). In
addition, moderate agreement (kappa = 0.38) was seen for
both PCR and LAMP ampliﬁcation for Qiagen (Table 4). Similarly, PCR for Qiagen and LAMP for LAMP-PURE showed
moderate agreement (kappa = 0.30), but the test positives may
not be similar as evidenced from the Bowker’s symmetry
(5.26, P = 0.0218). On the other hand, 1) PCR-Qiagen and
PCR_LAMP-PURE and 2) LAMP-Qiagen and LAMP_LAMPPURE were highly unlikely to yield always the same result
(Table 4).
DISCUSSION
We found that LAMP is more sensitive in detecting low-level
infections, especially after MDA. Using well-deﬁned positive
and negative controls and 111 ﬁltered urine samples collected from school children after MDA, the LAMP assay for
the Qiagen-extracted DNA achieved 100% sensitivity, speciﬁcity, and accuracy with 94% disease prevalence (Table 3).
Moreover, LAMP-Qiagen detected 16% more positive infection than PCR ampliﬁcation for the Qiagen-extracted DNA
(Table 1). Polymerase chain reaction also performed well with
100% speciﬁcity and 83% sensitivity for Qiagen extraction.
The sensitivity of LAMP is being considered as 10 times higher
than PCR by previous study,24 and our ﬁndings are consistent
with such ﬁndings. The ﬁndings also signify the need for such
sensitive assays for low infection intensities, especially after
MDA, as it is evident from the performance of KK. The sensitivity of PCR and LAMP (Qiagen extraction only) is eight and
11 times higher than that of KK for the samples evaluated for
this particular study (Table 1). In addition, the ﬁndings in our
study for PCR and LAMP ampliﬁcation for PURE extraction
is consistent with ﬁndings reported elsewhere. The sensitivity
is high, ranging from 79% (PCR) to 88% (LAMP), but speciﬁcity is the issue (31% for PCR and only 14% for LAMP).
As PCR and LAMP both are sensitive molecular methods,
higher sensitivity is expected. The lower speciﬁcity could
probably be associated with the presence of inhibitors in the
extracted DNA.
The Qiagen kit is very reliable and produced quality DNA in
our previous studies. Also, it is a membrane-based DNA

extraction kit, which usually takes care of the inhibitors present in extracted DNA along with some protein and other
cellular debris. On the other hand, PURE is an enclosed system devoid of membrane, so there is less chance of contamination, but higher chances of having impurities in the
extracted DNA. The possible presence of impurities in the
extracted DNA may have led to the misdiagnosis of positive
samples and regarded them as true negatives. The presence
of inhibitors could have hindered the ampliﬁcation of the
species-speciﬁc repeat fragment by PCR and LAMP. Considering the fact that PURE has been designed for quick DNA
extraction, which is suitable for ﬁeld, it can, thus, be an integral
part of LAMP diagnosis. Other studies have been planned to
address this issue specially to evaluate the efﬁcacy of LAMP
ampliﬁcation based on PURE extraction for asymptomatic
individuals.
This study, however, may not provide a conclusive outcome
about LAMP’s superiority over PCR because of the limitation
of the sample size. To substantiate the assertion that LAMP is
superior over PCR, there would be a need to conduct studies
in various settings considering different prevalence rates of
schistosomiasis and with varying disease burdens among the
infected population. Another limitation of the study is the absence of baseline data that probably would have reﬂected the
efﬁcacy of the MDA for this particular population.
To determine the species-speciﬁc ampliﬁcation, we have
sequenced random samples to verify the ampliﬁed fragments
by both PCR and LAMP. All the sequences are matched
against NCBI GenBank, and they matched with the 121-bp
Sm1-7 repeat fragment (GenBank: M61098.1) for S. mansoni
with 100% identity. This indicates the speciﬁcity of the LAMP
primers and the uniqueness of the cell-free repeat fragment for
S. mansoni.
Misdiagnosis or underdiagnosis occurs often when the infection level is low, and this is true for the MDA program, where
traditional tests usually fail to detect the remaining infection or
reinfection.25 This study shows the usefulness of the LAMP
assay in the diagnosis of these low-level infections after MDA,
which is evident from the poor performance of KK. This is
highly important in determining the applicability of LAMP as a
ﬁeld diagnostic technique. Although LAMP may not be able to
quantify the disease burden, but increased sensitivity and
speciﬁcity will aid into identiﬁcation of the remaining infection
that has escaped the MDA. This will help in determining the
actual infection prevalence for the particular population going
through treatment and will ultimately determine the efﬁcacy of
the control program. Moreover, LAMP can be implemented as
an integrated diagnostic approach (POC test) for surveillance
and to determine the transmission foci by extending the
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testing for infected snails. Using LAMP as a POC diagnosis to
determine the disease prevalence, especially after MDA, will
help stakeholders to make informed decision for control
intervention.
Given the advantages and demonstrated performance of
LAMP, we anticipate that it will be suitable to use not only for
resource-poor environments but also for well-equipped health
facilities. Procedure for Ultra Rapid Extraction kit can also be
part of this process, and overall, LAMP-PURE can play an
important role in molecular xenomonitoring for S. mansoni.
Received February 8, 2019. Accepted for publication April 16, 2019.
Published online May 20, 2019.
Acknowledgments: We would like to acknowledge the participating
schools and their pupils in the study districts in Zambia; our ﬁeld
technicians, H. Sinsungwe and B. Malunda, for their technical assistance in sample processing and microscopic examination; and the
participants in the United States, who provided urine samples, which
are used as negative control. Schistosoma mansoni genomic DNA is
acquired from the Schistosomiasis Resource Center for distribution
by BEI Resources, NIAID, NIH: Genomic DNA from Adult Male and
Female S. mansoni, Strain NMRI, NR-28910.
Financial support: The Member Research Grant from the American
Society of Clinical Laboratory Science (ASCLS) Education and Research Fund supported this study. Also, partial support came from
Early Career Research award from Thrasher Research Fund (13344).
Authors’ addresses: Miriam Price, Austin Cyrs, and Nilanjan Lodh,
Department of Clinical Laboratory Science, College of Health Sciences, Marquette University, Milwaukee, WI, E-mails: miriam.price@
marquette.edu, ajcyrs@gmail.com, and nilanjan.lodh@marquette.edu.
Chummy S. Sikasunge, Department of Para-clinical Studies, The University of Zambia, Lusaka, Zambia, E-mail: chumsika@yahoo.co.uk.
James Mwansa, University Teaching Hospital, The University of
Zambia, Lusaka, Zambia, E-mail: mwansaj@gmail.com.

REFERENCES
1. Hotez PJ, Damania A, Barua A, Stanaway J, 2017. The ﬁrst
“London Declaration”: the Commonwealth and its neglected
tropical diseases. PLoS Negl Trop Dis 11: e0005321.
2. Herricks JR et al., 2017. The global burden of disease study 2013:
what does it mean for the NTDs? PLoS Negl Trop Dis 11:
e0005424.
3. Colley DG, Bustinduy AL, Secor WE, King CH, 2014. Human
schistosomiasis. Lancet 383: 2253–2264.
4. King CH, Dangerﬁeld-Cha M, 2008. The unacknowledged impact
of chronic schistosomiasis. Chronic Ill 4: 65–79.
5. Hotez PJ, Fenwick A, 2009. Schistosomiasis in Africa: an
emerging tragedy in our new global health decade. PLoS
Negl Trop Dis 3: e485.
6. Lodh N, Mwansa JC, Mutengo MM, Shiff CJ, 2013. Diagnosis of
Schistosoma mansoni without the stool: comparison of three
diagnostic tests to detect Schistosoma mansoni infection from
ﬁltered urine in Zambia. Am J Trop Med Hyg 89: 46–50.
7. Xu J, Guan Z-X, Zhao B, Wang Y-Y, Cao Y, Zhang H-Q, Zhu X-Q,
He Y-K, Xia C-M, 2015. DNA detection of Schistosoma japonicum: diagnostic validity of a LAMP assay for low-intensity
infection and effects of chemotherapy in humans. PLoS Negl
Trop Dis 9: e0003668.
8. Hotez PJ, Pecoul B, Rijal S, Boehme C, Aksoy S, Malecela M,
Tapia-Conyer R, Reeder JC, 2016. Eliminating the neglected
tropical diseases: translational science and new technologies.
PLoS Negl Trop Dis 10: e0003895.
9. Enk MJ, Oliveira e Silva G, Rodrigues NB, 2012. Diagnostic accuracy and applicability of a PCR system for the detection of
Schistosoma mansoni DNA in human urine samples from an
endemic area. PLoS One 7: e38947.

83

10. Hamburger J, He N, Abbasi I, Ramzy RM, Jourdane J, Ruppel A,
2001. Polymerase chain reaction assay based on a highly repeated sequence of Schistosoma haematobium: a potential
tool for monitoring schistosome-infested water. Am J Trop Med
Hyg 65: 907–911.
11. Pontes LA, Dias-Neto E, Rabello A, 2002. Detection by polymerase chain reaction of Schistosoma mansoni DNA in human
serum and feces. Am J Trop Med Hyg 66: 157–162.
12. Sandoval N, Siles-Lucas M, Perez-Arellano JL, Carranza C,
Puente S, Lopez-Aban J, Muro A, 2006. A new PCR-based
approach for the speciﬁc ampliﬁcation of DNA from different
Schistosoma species applicable to human urine samples.
Parasitology 133: 581–587.
13. Lodh N, Mikita K, Bosompem KM, Anyan WK, Quartey JK,
Otchere J, Shiff CJ, 2017. Point of care diagnosis of multiple
schistosome parasites: species-speciﬁc DNA detection in urine
by loop-mediated isothermal ampliﬁcation (LAMP). Acta Trop
173: 125–129.
14. Lodh N, Naples JM, Bosompem KM, Quartey J, Shiff CJ, 2014.
Detection of parasite-speciﬁc DNA in urine sediment obtained
by ﬁltration differentiates between single and mixed infections
of Schistosoma mansoni and S. haematobium from endemic
areas in Ghana. PLoS One 9: e91144.
15. Ibironke O, Koukounari A, Asaolu S, Moustaki I, Shiff C, 2012.
Validation of a new test for Schistosoma haematobium based
on detection of Dra1 DNA fragments in urine: evaluation
through latent class analysis. PLoS Negl Trop Dis 6: e1464.
16. Kouzaki Y et al., 2015. PURE-LAMP procedure for the diagnosis
of extrapulmonary tuberculosis: a case series. Intern Med 54:
1447–1450.
17. Verweij JJ, Brienen EA, Ziem J, Yelifari L, Polderman AM, Van
Lieshout L, 2007. Simultaneous detection and quantiﬁcation
of Ancylostoma duodenale, Necator americanus, and Oesophagostomum bifurcum in fecal samples using multiplex realtime PCR. Am J Trop Med Hyg 77: 685–690.
18. Abbasi I, King CH, Muchiri EM, Hamburger J, 2010. Detection of
Schistosoma mansoni and Schistosoma haematobium DNA by
loop-mediated isothermal ampliﬁcation: identiﬁcation of infected snails from early prepatency. Am J Trop Med Hyg 83:
427–432.
19. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K,
Amino N, Hase T, 2000. Loop-mediated isothermal ampliﬁcation of DNA. Nucleic Acids Res 28: E63.
20. Gandasegui J, Fernández-Soto P, Muro A, Simões Barbosa C,
Lopes de Melo F, Loyo R, de Souza Gomes EC, 2018. A ﬁeld
survey using LAMP assay for detection of Schistosoma mansoni in a low-transmission area of schistosomiasis in Umbuzeiro, Brazil: assessment in human and snail samples. PLoS
Negl Trop Dis 12: e0006314.
21. Kawano S, Maeda T, Suzuki T, Abe T, Mikita K, Hamakawa Y, Ono
T, Sonehara W, Miyahira Y, Kawana A, 2015. Loop-mediated
isothermal ampliﬁcation with the procedure for ultra rapid extraction kit for the diagnosis of pneumocystis pneumonia.
J Infect Chemother 21: 224–226.
22. Lamberton PHL, Kabatereine NB, Oguttu DW, Fenwick A,
Webster JP, 2014. Sensitivity and speciﬁcity of multiple KatoKatz thick smears and a circulating cathodic antigen test for
Schistosoma mansoni diagnosis pre- and post-repeatedpraziquantel treatment. PLoS Negl Trop Dis 8: e3139.
23. Anne K, Sonja K, 2007. Bowker’s test for symmetry and modiﬁcations within the algebraic framework. Comput Stat Data Anal
51: 4124–4142.
24. Hamburger J, Abbasi I, Kariuki C, Wanjala A, Mzungu E, Mungai P,
Muchiri E, King CH, 2013. Evaluation of loop-mediated isothermal ampliﬁcation suitable for molecular monitoring of
schistosome-infected snails in ﬁeld laboratories. Am J Trop
Med Hyg 88: 344–351.
25. Basuni M, Muhi J, Othman N, Verweij JJ, Ahmad M, Miswan N,
Rahumatullah A, Aziz FA, Zainudin NS, Noordin R, 2011.
A pentaplex real-time polymerase chain reaction assay for
detection of four species of soil-transmitted helminths. Am J
Trop Med Hyg 84: 338–343.

